Understanding Immune Responses to Tuberculosis
Regulators of IFN-gamma responses during Mycobacterium tuberculosis infection
['FUNDING_R01'] · MICHIGAN STATE UNIVERSITY · NIH-11126018
This project aims to better understand how our immune system fights tuberculosis, hoping to find new ways to treat or prevent this serious infection.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MICHIGAN STATE UNIVERSITY (nih funded) |
| Locations | 1 site (EAST LANSING, UNITED STATES) |
| Trial ID | NIH-11126018 on ClinicalTrials.gov |
What this research studies
Tuberculosis (TB) is a major global health concern, and current treatments are long and there's no effective vaccine. We need to find new ways to shorten treatment and boost our body's defenses against TB. This work focuses on a key immune signal called interferon gamma (IFNγ), which is vital for fighting TB, but we don't fully understand how it works. Researchers are using advanced genetic tools to uncover the specific pathways that IFNγ uses to protect us, particularly how it helps immune cells present information to other protective cells.
Who could benefit from this research
Good fit: This foundational research is not directly recruiting patients but aims to benefit anyone affected by or at risk of tuberculosis in the future.
Not a fit: Patients seeking immediate new treatments will not directly benefit from this basic science research, as it is focused on fundamental understanding.
Why it matters
Potential benefit: If successful, this work could lead to the development of new treatments or vaccines that more effectively target the immune system to fight tuberculosis.
How similar studies have performed: This research builds on existing knowledge about IFNγ's role in immunity but uses novel genetic screening approaches to uncover previously unknown mechanisms.
Where this research is happening
EAST LANSING, UNITED STATES
- MICHIGAN STATE UNIVERSITY — EAST LANSING, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: OLIVE, ANDREW — MICHIGAN STATE UNIVERSITY
- Study coordinator: OLIVE, ANDREW
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.